A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
Condition: Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma Interventions: Drug: cabozantinib; Drug: nivolumab Sponsor: Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials